Home » Topics » BioWorld

BioWorld
RSS

PMA PREDICTS BIOTECH BOTTLENECK

Jan. 17, 1991

ddI HOLDS HOPE FOR CHILDREN WITH AIDS

Jan. 17, 1991

JOURNAL SCAN:

Jan. 17, 1991

NEWS BRIEFS

Jan. 17, 1991

CARRINGTON TO SELL CONVERTIBLE DEBENTURES

Jan. 17, 1991

MGI SELLS LAST STAKE IN BIOTECHNOLOGY

Jan. 16, 1991

MICROGENESYS AIDS VACCINE SHOWN SAFE

Jan. 16, 1991

EARNINGS REPORTS

Jan. 16, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 16, 1991

COMPANY PROFILES: SPHINX, OXFORD, BIOS

Jan. 16, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.